查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1717753

急性缺血性脑中风诊断市场（按产品类型、检测类型、疾病类型、技术和最终用户划分）—2025 年至 2030 年全球预测

Acute Ischemic Stroke Diagnosis Market by Product Type, Test Type, Disease Type, Technology, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

急性缺血性脑中风诊断市场预计到 2024 年将达到 37.7 亿美元，2025 年将达到 39.9 亿美元，到 2030 年将达到 55.9 亿美元，复合年增长率为 6.81%。

主要市场统计数据
基准年2024年 37.7亿美元
预计2025年 39.9亿美元
预测年份 2030 55.9亿美元
复合年增长率（%） 6.81%

急性缺血性脑中风是我们这个时代最严重的医疗紧急情况之一，几秒钟的时间就能决定结果和復原轨迹。在医疗保健以惊人的速度不断创新的时代，快速诊断这种疾病至关重要，以确保及时干预并减轻延迟治疗的破坏性后果。在医疗图像影像、生物标记检测和整体临床实践的推动下，急性缺血性脑中风诊断领域取得了重大进展。随着诊断技术的进步，我们对缺血事件相关的潜在病理生理学和风险因素的理解也不断加深。从临床医生到决策者，医疗保健领域的相关人员越来越注重利用尖端技术以无与伦比的准确度识别中风的发生。

世界人口的高发生率和快速老化凸显了预防性诊断的重要性。世界各地的卫生系统都在投资基础设施升级和研究创新，以应对这项公共卫生挑战。采用先进的影像诊断和血液生物标记评估的早期检测技术不仅有助于确定快速治疗方案，而且还有助于减少长期残疾和医疗负担。在这样一个动态的环境中，全面了解当前趋势、跨技术细分和地理变化至关重要。本执行摘要深入探讨了这些转型方面，并为寻求优化诊断范例和改善病患结果的相关人员提供了清晰的蓝图。

改变急性缺血性脑中风诊断市场

急性缺血性脑中风诊断的轨迹正在透过技术、临床实践和监管动态的一系列变革性转变进行重新定义。近年来，诊断影像和生物标记检测的突破性进展改变了临床医生诊断中风的方式。为了提高诊断通讯协定的准确性和速度，人们对整合即时数据分析和人工智慧的兴趣日益浓厚。这种方法不仅加快了决策流程，而且还有助于制定更适合每个患者特定需求的个人化治疗计划。

先进的 CT 扫描仪和 MRI 系统等诊断设备的创新使临床医生能够比以往更清晰地观察大脑内部事件。此外，即时检验和基于生物标记的检测的出现为提高紧急情况下的诊断准确性铺平了道路。积极的监管环境促进了这些技术进步，鼓励旨在微调现有方法的研究和临床试验。

随着监管机构适应技术创新的快速步伐，他们越来越多地支持简化新诊断工具核准同时确保其安全性和有效性的倡议。下一代诊断模式与现有临床实践的结合正在创造一个可以实现快速、可靠且经济高效的诊断的环境。技术创新和监管支援的协同效应正在塑造中风护理的新标准，并显着改善世界各地患者的治疗效果。

中风诊断中的关键节段分析

详细的細項分析反映了急性缺血性脑中风诊断市场的多样性，揭示了满足各种临床需求和技术进步的多方面层次。细分方法首先关注产品类型，并跨血液生物标记、颈动脉超音波、诊断影像和脑电图等细分市场进行检查。在诊断影像领域，将进一步探讨 CT 扫描仪和 MRI 系统的重要性，以展示影像技术在应对急性疾病方面的发展。同时，检测类型划分区分实验室检测和代谢组，实验室检测进一步细分为血液检测和影像检查，突显了生化分析在中风检测中的重要角色。

此外，在考虑疾病类型时，市场分析将缺血性中风分为栓塞性、腔隙性和血栓性亚型。这将使我们能够更细緻地了解如何透过客製化的诊断方法有效地治疗不同的中风症状。此外，技术细分区分了基于生物标记的检测方法和就地检验，突显了可携式和快速诊断解决方案的持续进步。最后，最终用户细分涵盖了广泛的应用，反映了门诊手术中心、诊断中心、医院、诊所和实验室的使用。这个全面的细分框架不仅提供了对当前市场动态的洞察，而且还为该领域未来的发展提供了策略基础。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 急性缺血性脑中风病例增加
      • 提高对早期中风检测益处的认识
      • 增加对发展中地区医疗基础建设的投资
    • 限制因素
      • 先进成像技术高成本
    • 机会
      • 整合机器人技术和人工智慧以实现高级诊断
      • 用于现场快速诊断的携带式诊断成像设备的开发
    • 任务
      • 缺乏熟练的医疗保健专业人员
  • 市场区隔分析
    • 产品类型：对血液生物标记的需求不断增长，用于快速检测和促进个人化治疗方法
    • 最终用户：便利性和成本效益推动了门诊手术中心对急性缺血性脑中风诊断的采用率提高
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章急性缺血性脑中风诊断市场（依产品类型）

  • 血液生物标记
  • 颈动脉超音波
  • 诊断影像
    • 电脑断层扫描（CT）扫描仪
    • MRI系统
  • 脑电图（EEG）

第七章急性缺血性脑中风诊断市场（依测试类型）

  • 实验室筛检
    • 血液检查
    • 影像检查
  • 代谢组

第八章急性缺血性脑中风诊断市场（依疾病类型）

  • 栓塞
  • 空白
  • 血栓性

第九章急性缺血性脑中风诊断市场（依技术）

  • 基于生物标记的检测
  • 就地检验

第 10 章急性缺血性脑中风诊断市场（依最终用户）

  • 门诊手术中心
  • 诊断中心
  • 医院和诊所
  • 研究部门

11.美洲急性缺血性脑中风中风诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区急性缺血性脑中风诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲急性缺血性脑中风诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • Aidoc Medical Ltd.
  • BIOTRONIK SE & Co KG
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corporation
  • GE Healthcare Technologies Inc.
  • Hitachi, Ltd.
  • Integral Diagnostics（IDX）Group
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Mediso Ltd.
  • Medtronic PLC
  • Merck & Co.
  • Neusoft Corporation
  • Nihon Kohden Corporation
  • Planmed Oy
  • Samsung Electronics Co. Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Shionogi & Co., Ltd.
  • Siemens Healthineers
  • Stryker Corporation
  • Toshiba International Corporation
Product Code: MRR-B16853776EA8

The Acute Ischemic Stroke Diagnosis Market was valued at USD 3.77 billion in 2024 and is projected to grow to USD 3.99 billion in 2025, with a CAGR of 6.81%, reaching USD 5.59 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 3.77 billion
Estimated Year [2025] USD 3.99 billion
Forecast Year [2030] USD 5.59 billion
CAGR (%) 6.81%

Acute ischemic stroke represents one of the most critical medical emergencies of our time, where seconds can define outcomes and determine recovery trajectories. In an era where healthcare continues to innovate at an extraordinary pace, the rapid diagnosis of this condition is paramount for ensuring timely intervention and mitigating the potentially devastating consequences of delayed treatment. The landscape of acute ischemic stroke diagnosis has seen significant advancements, driven by improvements in medical imaging, biomarker detection, and overall clinical practices. As diagnostic technologies evolve, so too does our understanding of the underlying pathophysiology and risk factors associated with ischemic events. Stakeholders across the healthcare sector-from clinical practitioners to decision-makers-are increasingly focused on leveraging cutting-edge methodologies to pinpoint the onset of stroke with unparalleled accuracy.

The importance of proactive diagnosis is accentuated by the high incidence rates and the rapidly aging global population. Health systems worldwide are investing in both infrastructural upgrades and research innovations to address this public health challenge. Early detection techniques using advanced imaging modalities and blood biomarker assessments not only aid in swift therapeutic decision-making but also contribute to reducing long-term disability and healthcare burdens. In this dynamic environment, a comprehensive understanding of current trends, segmentation across technologies, and geographical shifts is essential. This executive summary serves as a deep dive into these transformational aspects, offering a clear road map for stakeholders intent on optimizing diagnostic paradigms and improving patient outcomes.

Transformative Shifts in the Diagnostic Landscape

The trajectory of acute ischemic stroke diagnosis is being redefined by a series of transformative shifts in technology, practice, and regulatory dynamics. Over recent years, breakthroughs in imaging and biomarker detection have revolutionized how clinicians approach stroke diagnosis. There is a heightened focus on integrating real-time data analytics and artificial intelligence to enhance the precision and speed of diagnostic protocols. This approach not only speeds up the decision-making process but also facilitates personalized treatment plans that are better aligned with the specific needs of each patient.

Innovations in diagnostic equipment, such as advanced computed tomography (CT) scanners and magnetic resonance imaging (MRI) systems, have enabled clinicians to visualize cerebral events with greater clarity than ever before. Additionally, the advent of point-of-care testing and biomarker-based detection has paved the way for enhanced diagnostic accuracy in emergent scenarios. These technological advancements are complemented by a proactive regulatory landscape that encourages research and clinical trials aimed at fine-tuning existing methodologies.

As regulatory bodies adapt to the rapid pace of innovation, they are increasingly supporting initiatives that streamline the approval of new diagnostic tools while ensuring safety and efficacy. The integration of next-generation diagnostic modalities with established clinical practices is creating an environment where rapid, reliable, and economically efficient diagnosis becomes a reality. The synergy between technological innovation and regulatory support is forging a new standard in stroke care, markedly improving outcomes for patients worldwide.

Key Segmentation Insights in Stroke Diagnosis

A detailed segmentation analysis reflects the diverse nature of the acute ischemic stroke diagnosis market, revealing multifaceted layers that cater to various clinical needs and technological advancements. The segmentation approach begins by focusing on product type, where the market is studied across segments including blood biomarker, carotid ultrasound, diagnostic imaging, and electroencephalography. Within diagnostic imaging, further investigations highlight the significance of computed tomography (CT) scanners and MRI systems, showcasing the evolution of imaging techniques in addressing acute conditions. Concurrently, the test type segmentation distinguishes between lab tests and metabolic panels, with lab tests further subdivided into blood tests and imaging tests, emphasizing the critical role of biochemical analyses in stroke detection.

Furthermore, when examining disease type, the market analysis categorizes ischemic stroke into embolic, lacunar, and thrombotic subtypes. This allows a more nuanced understanding of how different stroke manifestations can be more effectively managed with tailored diagnostic approaches. Additionally, the technological segmentation distinguishes between biomarker-based detection methods and point-of-care testing, underscoring the continuous advancement in portable and rapid diagnostic solutions. Lastly, the end-user segmentation covers a wide range of applications, reflecting usage in ambulatory surgical centers, diagnostic centers, hospitals and clinics, as well as research laboratories. This comprehensive segmentation framework not only provides insights into current market dynamics but also offers a strategic foundation for future advancements in the field.

Based on Product Type, market is studied across Blood Biomarker, Carotid Ultrasound, Diagnostic Imaging, and Electroencephalography. The Diagnostic Imaging is further studied across Computed Tomography (CT) Scanner and MRI System.

Based on Test Type, market is studied across Lab Tests and Metabolic Panel. The Lab Tests is further studied across Blood Test and Imaging Tests.

Based on Disease Type, market is studied across Embolic, Lacunar, and Thrombotic.

Based on Technology, market is studied across Biomarker-Based Detection and Point Of Care Testing.

Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Hospitals & Clinics, and Research Laboratories.

Key Regional Insights in the Stroke Diagnosis Market

The regional dynamics of the acute ischemic stroke diagnostic market reveal significant heterogeneity and robust growth patterns across major global regions. In the Americas, a strong emphasis on state-of-the-art medical facilities combined with an increasing prevalence of cerebrovascular diseases creates a conducive environment for rapid adoption of innovative diagnostic technologies. This region is characterized by substantial investments in healthcare infrastructure and a proactive approach to continuous medical advancements, ensuring high uptake of cutting-edge imaging and testing modalities.

In regions spanning Europe, the Middle East, and Africa, the emphasis on developing extensive healthcare networks and improving access to advanced medical technologies is evident. These regions are witnessing an upward trend in the integration of comprehensive diagnostic platforms that support rapid decision-making in stroke management. The collaborative efforts between governments and healthcare providers are fostering environments that embrace emerging diagnostic trends while enhancing patient care standards.

Asia-Pacific is another fast-growing market where the dual forces of technological innovation and a rapidly expanding healthcare framework are driving significant investments in the stroke diagnosis segment. Government initiatives aimed at improving public health, coupled with an increasing awareness of stroke symptoms and preventive care, are fueling demand for advanced diagnostic solutions. In all these regions, the regional insights point to a gradual harmonization of technology and policy that bodes well for the future of acute ischemic stroke diagnosis.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Insights Shaping the Market

The market is further defined by the substantial influence of key industry players who continue to drive innovation and shape the competitive landscape. Renowned companies such as Abbott Laboratories and Aidoc Medical Ltd. are at the forefront, leveraging robust research and development platforms to introduce novel diagnostic solutions into the market. Prominent players including BIOTRONIK SE & Co KG, Boehringer Ingelheim International GmbH, and Boston Scientific Corporation are contributing through strategic investments in advanced medical technologies and comprehensive healthcare solutions. Canon Medical Systems Corporation and F. Hoffmann-La Roche Ltd. bring their expertise to bear with sophisticated diagnostic imaging and analytical tools designed to enhance clinical precision.

Fujifilm Holdings Corporation and GE Healthcare Technologies Inc. are shaping the trajectory with innovations in imaging modalities, while suppliers like Hitachi, Ltd., and Integral Diagnostics (IDX) Group are emerging as critical contributors in the diagnostic domain. Further, Johnson & Johnson Services, Inc. and Koninklijke Philips N.V. are solidifying their positions through continuous technological enhancements and targeted market strategies. Mediso Ltd., Medtronic PLC, and Merck & Co. have all demonstrated a steadfast commitment to research, quality, and clinical excellence. In addition, companies such as Neusoft Corporation and Nihon Kohden Corporation are expanding the horizons of diagnostic solutions, while Planmed Oy, Samsung Electronics Co. Ltd., and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. are swiftly adapting to the evolving market demands. Shimadzu Corporation, Shionogi & Co., Ltd., Siemens Healthineers, Stryker Corporation, and Toshiba International Corporation round out the list of influential names that are setting new benchmarks in acute ischemic stroke diagnosis, contributing to the overall growth and dynamic evolution of the market.

The report delves into recent significant developments in the Acute Ischemic Stroke Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aidoc Medical Ltd., BIOTRONIK SE & Co KG, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Canon Medical Systems Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., Hitachi, Ltd., Integral Diagnostics (IDX) Group, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Mediso Ltd., Medtronic PLC, Merck & Co., Neusoft Corporation, Nihon Kohden Corporation, Planmed Oy, Samsung Electronics Co. Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Shionogi & Co., Ltd., Siemens Healthineers, Stryker Corporation, and Toshiba International Corporation. Actionable Recommendations for Industry Leaders

To navigate the evolving landscape of acute ischemic stroke diagnosis, industry leaders are encouraged to adopt a multifaceted strategy that is both proactive and innovative. A key recommendation is to invest in research and development initiatives that emphasize the integration of advanced imaging and biomarker technologies. Bridging the gap between laboratory precision and real-time point-of-care testing is essential, and leaders should strategically cultivate partnerships that foster technological convergence in these areas.

Expanding geographic footprints is another important consideration. Investing in markets that exhibit robust growth indicators, such as the Americas, Europe, the Middle East, Africa, and Asia-Pacific, can offer significant advantages. Leaders are advised to invest in localized product development and market-specific strategies that cater to the unique regulatory and infrastructural demands of each region. This will not only accelerate market penetration but also enhance the overall adoption of cutting-edge diagnostic solutions.

It is also critical for decision-makers to continuously monitor emerging trends and to remain agile in adapting their business models. The incorporation of digital tools and data analytics can provide valuable insights into patient outcomes and diagnostic efficacy. Embracing such innovations will help in refining product portfolios and ensuring that the diagnostic methodologies remain at the cutting edge of clinical practice. Industry leaders must establish cross-functional teams that can respond swiftly to market shifts and regulatory changes, positioning themselves as pioneers in transforming acute ischemic stroke diagnosis.

Conclusion on Diagnostics and Market Evolution

In summation, the landscape of acute ischemic stroke diagnosis is undergoing a dynamic transformation underpinned by technological innovations, strategic segmentation, and robust regional investments. The evolution of diagnostic methodologies-from advanced imaging systems to real-time biomarker detections-has dramatically transformed clinical practices and patient outcomes. The detailed segmentation analysis, emphasizing product type, test type, disease type, technology, and end-user applications, offers insight into a market that is both diverse and rapidly advancing. With significant contributions from key companies worldwide and substantial regional investments, the contemporary diagnostic environment is geared towards more effective intervention strategies.

The ongoing shift in research, technology, and regulatory paradigms is setting the stage for a future where precise, timely, and accessible diagnostics become the norm. Health systems, clinicians, and industry leaders stand at a unique juncture where integrating these multifaceted developments can lead to significant improvements in stroke management and patient care outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of acute ischemic stroke cases
      • 5.1.1.2. Rising awareness about early stroke detection benefits
      • 5.1.1.3. Growing investment in healthcare infrastructure in developing regions
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of advanced imaging techniques
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of robotics and AI for advanced diagnostics
      • 5.1.3.2. Development of portable imaging devices for faster on-site diagnosis
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled healthcare professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising need for blood biomarkers for rapid testing and facilitating personalized treatment approaches
    • 5.2.2. End-User: Increasing adoption of acute ischemic stroke diagnosis in ambulatory surgical centers owing to convenience and cost-efficiency
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acute Ischemic Stroke Diagnosis Market, by Product Type

  • 6.1. Introduction
  • 6.2. Blood Biomarker
  • 6.3. Carotid Ultrasound
  • 6.4. Diagnostic Imaging
    • 6.4.1. Computed Tomography (CT) Scanner
    • 6.4.2. MRI System
  • 6.5. Electroencephalography

7. Acute Ischemic Stroke Diagnosis Market, by Test Type

  • 7.1. Introduction
  • 7.2. Lab Tests
    • 7.2.1. Blood Test
    • 7.2.2. Imaging Tests
  • 7.3. Metabolic Panel

8. Acute Ischemic Stroke Diagnosis Market, by Disease Type

  • 8.1. Introduction
  • 8.2. Embolic
  • 8.3. Lacunar
  • 8.4. Thrombotic

9. Acute Ischemic Stroke Diagnosis Market, by Technology

  • 9.1. Introduction
  • 9.2. Biomarker-Based Detection
  • 9.3. Point Of Care Testing

10. Acute Ischemic Stroke Diagnosis Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Diagnostic Centers
  • 10.4. Hospitals & Clinics
  • 10.5. Research Laboratories

11. Americas Acute Ischemic Stroke Diagnosis Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Acute Ischemic Stroke Diagnosis Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Acute Ischemic Stroke Diagnosis Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. University Hospitals awarded USD 7 million by PCORI to study endovascular thrombectomy
    • 14.3.2. PP-007 receives FDA fast track designation for treatment of acute ischemic stroke
    • 14.3.3. StrokeDx secures USD 5M funding to enhance non-invasive stroke detection technology and expand market reach
    • 14.3.4. China Medical University Hospital's AISIA AI platform revolutionizes ischemic stroke diagnosis with rapid, accurate, and sensitive deep learning models, enhancing patient outcomes and reducing long-term costs
    • 14.3.5. CERENOVUS launches CEREGLIDE 71 Intermediate Catheter with TruCourse technology, advancing acute ischemic stroke treatment
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aidoc Medical Ltd.
  • 3. BIOTRONIK SE & Co KG
  • 4. Boehringer Ingelheim International GmbH
  • 5. Boston Scientific Corporation
  • 6. Canon Medical Systems Corporation
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Fujifilm Holdings Corporation
  • 9. GE Healthcare Technologies Inc.
  • 10. Hitachi, Ltd.
  • 11. Integral Diagnostics (IDX) Group
  • 12. Johnson & Johnson Services, Inc.
  • 13. Koninklijke Philips N.V.
  • 14. Mediso Ltd.
  • 15. Medtronic PLC
  • 16. Merck & Co.
  • 17. Neusoft Corporation
  • 18. Nihon Kohden Corporation
  • 19. Planmed Oy
  • 20. Samsung Electronics Co. Ltd.
  • 21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 22. Shimadzu Corporation
  • 23. Shionogi & Co., Ltd.
  • 24. Siemens Healthineers
  • 25. Stryker Corporation
  • 26. Toshiba International Corporation

LIST OF FIGURES

  • FIGURE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET MULTI-CURRENCY
  • FIGURE 2. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET MULTI-LANGUAGE
  • FIGURE 3. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET RESEARCH PROCESS
  • FIGURE 4. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY BLOOD BIOMARKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY CAROTID ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY MRI SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY METABOLIC PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY EMBOLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LACUNAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY THROMBOTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY BIOMARKER-BASED DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD